Furthermore, it has been documented that heightened Tim-3 levels are linked to the emergence of resistance against PD-1 blockade, evident in both lung cancer patient samples and lung cancer models, as well as samples taken from patients with head and neck cancer (222, 223). Here, HAVCR2 is linked to lung carcinoma.